virtualcoin- Top See results about

Morgan Stanley raised the opening target price from $950.00 to $1,150.00.Minister of Economy of Slovakia: From next week, we will hold a series of negotiations on natural gas supply, including with EU partners and Ukraine.Market News: Riot Blockchain(RIOT.O) acquired 5,117 bitcoins for $510 million.

Morgan Stanley kept Apple's target price at $273.00.Huilv Ecology: The plan to increase capital to Junheng Technology to achieve control constitutes a major asset restructuring. Huilv Ecology announced that the company and Peng Kaisheng plan to increase capital to Wuhan Junheng Technology Co., Ltd. by paying cash. Before this capital increase, listed companies held 35% equity of Junheng Technology. After this capital increase is completed, listed companies will hold 51% equity of Junheng Technology to control Junheng Technology and include Junheng Technology in the scope of consolidated statements. The total consideration of this transaction is 246 million yuan, all of which are paid in cash. According to the relevant provisions of the Measures for the Administration of Major Asset Restructuring of Listed Companies, this transaction constitutes a major asset restructuring.Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.

The institution is optimistic about these stocks today. On December 13th, as of press time, the institution gave 20 latest buy ratings, among which the target price of 9 stocks was announced:-Cobos was optimistic about UBS Securities, giving a target price of 62.00 yuan; -Yingqu Technology was favored by Guotai Junan with a target price of 19.25 yuan; -Yutong Bus, Jinkong Coal Industry, Dong 'e Ejiao and many other stocks are listed.Nasdaq hit a record high in intraday trading, up 0.8%.Jiaying Pharmaceutical Co., Ltd.: It plans to buy back 7 million to 13.5 million shares. Jiaying Pharmaceutical announced that it plans to use its own funds to buy back some issued RMB common shares (A shares) by centralized bidding for the implementation of employee stock ownership plan or equity incentive. The price of repurchased shares is not higher than 9.80 yuan/share (inclusive), and the number of shares to be repurchased is not less than 7 million shares (inclusive), accounting for about 1.3793% of the company's total share capital; And no more than 13.5 million shares (inclusive), accounting for about 2.6600% of the company's total share capital. The repurchase period is within 12 months from the date when the company's board of directors deliberated and approved the share repurchase plan.